BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 35729111)

  • 21. Cell Viability Assays for Candida auris.
    Brown JL; Short B; Ware A; Sherry L; Kean R; Ramage G
    Methods Mol Biol; 2022; 2517():129-153. PubMed ID: 35674950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissemination of Candida auris to deep organs in neonatal murine invasive candidiasis.
    Flores-Maldonado O; González GM; Andrade A; Montoya A; Treviño-Rangel R; Silva-Sánchez A; Becerril-García MA
    Microb Pathog; 2021 Dec; 161(Pt B):105285. PubMed ID: 34774701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of
    Fan S; Zhan P; Bing J; Jiang N; Huang Y; Chen D; Hu T; Du H; Huang G
    Virulence; 2021 Dec; 12(1):1388-1399. PubMed ID: 34060424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Bibliometric Review on
    Villanueva-Lozano H; Trejo-Castro AI; Carrion-Alvarez D; Lozano-Díaz ST; Martinez-Torteya A
    Biomed Res Int; 2023; 2023():2385018. PubMed ID: 37869631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris.
    Tran HNH; Graham L; Adukwu EC
    Appl Microbiol Biotechnol; 2020 Oct; 104(20):8911-8924. PubMed ID: 32880694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
    J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.
    Fernandes L; Ribeiro R; Henriques M; Rodrigues ME
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1371-1385. PubMed ID: 36198878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drosophila melanogaster as a Rapid and Reliable In Vivo Infection Model to Study the Emerging Yeast Pathogen Candida auris.
    Wurster S; Albert ND; Kontoyiannis DP
    Methods Mol Biol; 2022; 2517():299-316. PubMed ID: 35674964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of pathogenicity for the emerging fungus Candida auris.
    Horton MV; Holt AM; Nett JE
    PLoS Pathog; 2023 Dec; 19(12):e1011843. PubMed ID: 38127686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of Iron Homeostasis and Mitochondrial Metabolism Are Promising Targets to Inhibit Candida auris.
    Simm C; Weerasinghe H; Thomas DR; Harrison PF; Newton HJ; Beilharz TH; Traven A
    Microbiol Spectr; 2022 Apr; 10(2):e0010022. PubMed ID: 35412372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspective on the origin, resistance, and spread of the emerging human fungal pathogen Candida auris.
    Sharma C; Kadosh D
    PLoS Pathog; 2023 Mar; 19(3):e1011190. PubMed ID: 36952448
    [No Abstract]   [Full Text] [Related]  

  • 32. Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model.
    Wurster S; Albert ND; Kontoyiannis DP
    mSphere; 2022 Apr; 7(2):e0081721. PubMed ID: 35224979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Mouse Models of Disseminated Candida auris Infection.
    Xin H; Mohiuddin F; Tran J; Adams A; Eberle K
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host-pathogen interactions upon
    Garcia-Bustos V; Pemán J; Ruiz-Gaitán A; Cabañero-Navalon MD; Cabanilles-Boronat A; Fernández-Calduch M; Marcilla-Barreda L; Sigona-Giangreco IA; Salavert M; Tormo-Mas MÁ; Ruiz-Saurí A
    Emerg Microbes Infect; 2022 Dec; 11(1):136-146. PubMed ID: 34890523
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular and Extracellular Vesicle RNA Analysis in the Global Threat Fungus
    Munhoz da Rocha IF; Martins ST; Amatuzzi RF; Zamith-Miranda D; Nosanchuk JD; Rodrigues ML; Alves LR
    Microbiol Spectr; 2021 Dec; 9(3):e0153821. PubMed ID: 34908466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface.
    Welsh RM; Bentz ML; Shams A; Houston H; Lyons A; Rose LJ; Litvintseva AP
    J Clin Microbiol; 2017 Oct; 55(10):2996-3005. PubMed ID: 28747370
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Warris A
    Arch Dis Child; 2018 Sep; 103(9):891-894. PubMed ID: 29545411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
    Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
    mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris.
    Bruno M; Kersten S; Bain JM; Jaeger M; Rosati D; Kruppa MD; Lowman DW; Rice PJ; Graves B; Ma Z; Jiao YN; Chowdhary A; Renieris G; van de Veerdonk FL; Kullberg BJ; Giamarellos-Bourboulis EJ; Hoischen A; Gow NAR; Brown AJP; Meis JF; Williams DL; Netea MG
    Nat Microbiol; 2020 Dec; 5(12):1516-1531. PubMed ID: 32839538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.